Cargando…

Studies in schizophrenia: pathophysiology and treatment

Studies on the pathophysiology of schizophrenia have implicated the limbic cortex, using postmortem, structural, and functional data, especially in the hippocampus (HC) and the anterior cingulate cortex (ACC). We have made contributions to the literature consistent with this idea: first, we describe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamminga, Carol A., Medoff, Deborah R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Les Laboratoires Servier 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181694/
https://www.ncbi.nlm.nih.gov/pubmed/22033751
_version_ 1782212791280599040
author Tamminga, Carol A.
Medoff, Deborah R.
author_facet Tamminga, Carol A.
Medoff, Deborah R.
author_sort Tamminga, Carol A.
collection PubMed
description Studies on the pathophysiology of schizophrenia have implicated the limbic cortex, using postmortem, structural, and functional data, especially in the hippocampus (HC) and the anterior cingulate cortex (ACC). We have made contributions to the literature consistent with this idea: first, we describe a positive significant correlation between psychotic symptoms in schizophrenia and neuronal activity in the ACC and HC, suggesting the involvement of limbic cortex in the mediation of symptoms in schizophrenia. Second, in the ACC and the anterior HC (but not in the posterior HC), regional cerebral blood flow (rCBF) is abnormal (ie, reduced in the ACC and elevated in the HC) in schizophrenia. Third, the relationship of rCBF to task difficulty in the ACC is altered in schizophrenia, suggesting a failure of participation of the ACC in effortful tasks. Lastly, connectivity between the ACC and HC during the performance of an auditory discrimination task is also lacking, suggesting that cognitive performance in schizophrenia lacks a functional limbic contribution. On the basis of these changes, we studied the effects of antipsychotic drugs in these abnormal areas in persons with schizophrenia. Both first- and second-generation antipsychotics produce functional alterations in these limbic cortical areas, in the direction of normals, putatively acting through the brain's own cortical-subcortical circuits.
format Online
Article
Text
id pubmed-3181694
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher Les Laboratoires Servier
record_format MEDLINE/PubMed
spelling pubmed-31816942011-10-27 Studies in schizophrenia: pathophysiology and treatment Tamminga, Carol A. Medoff, Deborah R. Dialogues Clin Neurosci Pharmacological Aspects Studies on the pathophysiology of schizophrenia have implicated the limbic cortex, using postmortem, structural, and functional data, especially in the hippocampus (HC) and the anterior cingulate cortex (ACC). We have made contributions to the literature consistent with this idea: first, we describe a positive significant correlation between psychotic symptoms in schizophrenia and neuronal activity in the ACC and HC, suggesting the involvement of limbic cortex in the mediation of symptoms in schizophrenia. Second, in the ACC and the anterior HC (but not in the posterior HC), regional cerebral blood flow (rCBF) is abnormal (ie, reduced in the ACC and elevated in the HC) in schizophrenia. Third, the relationship of rCBF to task difficulty in the ACC is altered in schizophrenia, suggesting a failure of participation of the ACC in effortful tasks. Lastly, connectivity between the ACC and HC during the performance of an auditory discrimination task is also lacking, suggesting that cognitive performance in schizophrenia lacks a functional limbic contribution. On the basis of these changes, we studied the effects of antipsychotic drugs in these abnormal areas in persons with schizophrenia. Both first- and second-generation antipsychotics produce functional alterations in these limbic cortical areas, in the direction of normals, putatively acting through the brain's own cortical-subcortical circuits. Les Laboratoires Servier 2002-12 /pmc/articles/PMC3181694/ /pubmed/22033751 Text en Copyright: © 2002 LLS http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Pharmacological Aspects
Tamminga, Carol A.
Medoff, Deborah R.
Studies in schizophrenia: pathophysiology and treatment
title Studies in schizophrenia: pathophysiology and treatment
title_full Studies in schizophrenia: pathophysiology and treatment
title_fullStr Studies in schizophrenia: pathophysiology and treatment
title_full_unstemmed Studies in schizophrenia: pathophysiology and treatment
title_short Studies in schizophrenia: pathophysiology and treatment
title_sort studies in schizophrenia: pathophysiology and treatment
topic Pharmacological Aspects
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181694/
https://www.ncbi.nlm.nih.gov/pubmed/22033751
work_keys_str_mv AT tammingacarola studiesinschizophreniapathophysiologyandtreatment
AT medoffdeborahr studiesinschizophreniapathophysiologyandtreatment